Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer.
Podrazil M, Horvath R, Becht E, Rozkova D, Bilkova P, Sochorova K, Hromadkova H, Kayserova J, Vavrova K, Lastovicka J, Vrabcova P, Kubackova K, Gasova Z, Jarolim L, Babjuk M, Spisek R, Bartunkova J, Fucikova J.
Podrazil M, et al. Among authors: vrabcova p.
Oncotarget. 2015 Jul 20;6(20):18192-205. doi: 10.18632/oncotarget.4145.
Oncotarget. 2015.
PMID: 26078335
Free PMC article.
Clinical Trial.